PET prediction of response to trastuzumab in ErbB2-positive human xenograft model.
J Nucl Med
; 53(10): 1654-5; author reply 1655-6, 2012 Oct.
Article
in En
| MEDLINE
| ID: mdl-22917885
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Breast Neoplasms
/
Receptor, ErbB-2
/
Xenograft Model Antitumor Assays
/
Positron-Emission Tomography
/
Antibodies, Monoclonal, Humanized
/
Antineoplastic Agents
Type of study:
Prognostic_studies
/
Risk_factors_studies
Limits:
Animals
/
Female
/
Humans
Language:
En
Journal:
J Nucl Med
Year:
2012
Document type:
Article